Profil
Joanne Kotz was the founder of Jnana Therapeutics, Inc. and held the title of Chief Executive Officer & Director from 2021 to 2024.
Dr. Kotz is currently the Chief Executive Officer & Director at Atalanta Therapeutics, Inc. since 2025 and a Member of the Chordoma Foundation.
Education includes an undergraduate degree from the University of Florida and a doctorate from the University of California.
Postes actifs de Joanne Kotz
| Sociétés | Poste | Début |
|---|---|---|
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Directeur Général | 18/06/2025 |
Chordoma Foundation
Chordoma Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that accelerates research to develop better treatments and a cure for the rare bone cancer chordoma | Directeur/Membre du Conseil | - |
Anciens postes connus de Joanne Kotz
| Sociétés | Poste | Fin |
|---|---|---|
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Fondateur | 01/11/2024 |
Formation de Joanne Kotz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
Chordoma Foundation
Chordoma Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that accelerates research to develop better treatments and a cure for the rare bone cancer chordoma | Commercial Services |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Commercial Services |
















